AI-Driven NHP BehaviorAtlas® System: High-Resolution 3D Behavioral Analytics for Translational Research
Quantifying non-human primate (NHP) behavior with precision, consistency, and translational relevance is one of the most persistent challenges in preclinical neuroscience, immunology, and drug safety research. Traditional behavioral assessments rely heavily on manual observation or marker-based motion capture systems-approaches that often introduce subjectivity, stressful handling, and limited data depth.
Prisys Biotech's AI-Based NHP BehaviorAtlas® System represents a fundamental shift from subjective description to objective, automated, and high-dimensional behavioral quantification. Powered by advanced computer vision, multi-view 3D motion capture, and deep learning algorithms, the system enables accurate, markerless, and stress-free behavioral analysis for a wide range of disease models and pharmacological studies.
A Next-Generation Platform for Quantitative NHP Behavioral Science
1. Markerless, Stress-Free Data Acquisition
Conventional motion analysis systems require reflective markers attached to the animal's body, which can alter natural behavior and compromise data validity.
The BehaviorAtlas® System uses a fully markerless design, identifying and tracking anatomical key points directly from synchronized multi-view video streams. This minimizes animal handling, enhances welfare compliance, and ensures that observed behavior reflects true physiological and emotional states.
2. Multi-View 3D Motion Capture with Millimeter Precision
Equipped with four or more high-speed, high-resolution cameras, the system reconstructs 3D skeletal models of NHPs with exceptional accuracy:
- Over 21 anatomical key points tracked in 3D
- Millimeter-level precision in movement and posture estimation
- Robust performance across complex environments, including climbing structures and enriched cages
This capability overcomes the limitations of single-view or 2D systems, providing a comprehensive quantification of movement dynamics, joint kinematics, and gait characteristics.
3. Deep Learning–Enabled Behavioral Classification
Beyond movement tracking, the system interprets behavioral sequences by combining:
- Unsupervised behavior segmentation
- Time series analysis with second-level resolution
- Automated recognition of more than 14 core behaviors, including walking, climbing, sitting, grooming, scratching, hanging, and exploratory activity
Output formats include:
- Ethograms
- Trajectory maps & heatmaps
- Quantitative behavioral endpoints for efficacy and safety pharmacology
This transforms NHP behavioral research from qualitative observation to reproducible scientific measurement.
Versatile Analysis Modules Designed for Preclinical R&D
1. Free-Movement Module - Naturalistic Behavioral Assessment
Ideal for CNS diseases, psychiatric conditions, long-term monitoring, and safety pharmacology.
Applications include:
- Parkinson's disease motor deficits
- Huntington's disease hyperkinesia
- Anxiety- and depression-related behaviors
- Drug-induced CNS effects (sedation, hallucination-like responses)
2. Treadmill Gait Analysis Module - High-Precision Kinematic Profiling
Enables gait quantification with parameters such as:
- Step length & width
- Swing/stance phase duration
- Symmetry indices
- Joint angle trajectories
Widely applied in:
- Rheumatoid arthritis (RA) models
- Pain and locomotor impairment studies
- Neuroregeneration and functional recovery assessments
3. Geometric Morphometrics Module - Facial Expression & Pain Indicators
Using AI-based facial action unit (AU) detection, the system quantifies subtle facial changes associated with:
- Pain perception
- Emotional states
- Social interaction responses
This module provides objective metrics for analgesics, CNS-active compounds, and behavioral toxicology studies.
Broad Applications Across Therapeutic Areas
Neuroscience & CNS Disorders
Parkinson's disease: bradykinesia, tremor, posture, gait
Alzheimer's disease: reduced exploration, activity changes
Stroke/MCAO: motor coordination and recovery
Epilepsy: automatisms, freezing episodes
Pain & Sensory Research
IL-31 pruritus model: scratch count and duration
Chronic pain (PSNL): hanging behavior, reduced mobility
Formalin test: biphasic nocifensive behavior characterization
Immunology & Inflammation
RA models: locomotor decline and functional restoration
Longitudinal inflammation studies
Drug Efficacy & Safety Assessment
Objective behavioral endpoints for PK/PD alignment
Automated quantification of drug-induced CNS effects
Visualization of psychedelic compound behavioral signatures
Advantages Over Traditional Behavioral Assessment Methods
| Feature | Manual / Marker-Based Systems | Prisys AI NHP BehaviorAtlas® System |
|---|---|---|
| Accuracy | Low to moderate | High; millimeter-level 3D precision |
| Objectivity | Observer-dependent | Fully automated, unbiased |
| Animal Stress | Marker attachment required | Markerless, low-stress |
| Throughput | Labor-intensive | High-throughput automated analysis |
| Data Depth | Limited endpoints | Rich kinematic & behavioral datasets |
| Translational Value | Variable | High; reproducible, quantifiable metrics |
Transforming NHP Behavior into Quantitative, Clinically Relevant Data
The NHP BehaviorAtlas® System elevates behavioral science into a mature analytical discipline-capable of capturing subtle phenotypes, detecting treatment effects earlier, and integrating behavior with imaging, PK/PD, and biomarker datasets for deep mechanistic insight.
By enabling objective, scalable, and high-resolution behavioral analytics, Prisys Biotech empowers researchers to accelerate drug discovery and improve translational predictability across CNS, pain, inflammation, and safety assessment programs.
To explore collaboration opportunities or request specific case studies, please contact the Prisys technical team.
